Use of gene expression signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo

Walder, Ken; Molero, J; Konstantopoulos, Nicky; Segal, D; Foletta, Victoria; Windmill, Kelly; Curran, J; Dyer, T; Shields, K; Jowett, Jeremy; Krippner, G; Blangero, J; Collier, Gregory

walder-geneexpression-2008.pdf (132.64 kB)

Use of gene expression signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo

conference contribution

posted on 2008-01-01, 00:00 authored by Ken WalderKen Walder, J Molero, Nicky Konstantopoulos, D Segal, Victoria Foletta, Kelly WindmillKelly Windmill, J Curran, T Dyer, K Shields, Jeremy Jowett, G Krippner, J Blangero, Gregory Collier

Use of gene expression signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo

History

Event

Australian Diabetes Society & Australian Diabetes Educators Association. Annual Scientific Meeting (2008 : Melbourne, Vic.)

Publisher

ADS & ADEA

Location

Melbourne, Vic.

Place of publication

[Melbourne, Vic.]

Start date

2008-08-28

End date

2008-08-30

Language

eng

Publication classification

E3.1 Extract of paper

Copyright notice

2008, ADS & ADEA

Title of proceedings

ADS-ADEA 2008 : Proceedings of the Australian Diabetes Society & Australian Diabetes Educators Association 2008 annual scientific meeting

Use of gene expression signature technology to identify VVP808, a novel insulin sensitiser with efficacy in vitro and in vivo

History

Event

Publisher

Location

Place of publication

Start date

End date

Language

Publication classification

Copyright notice

Title of proceedings

Usage metrics

Categories

Keywords

Licence

Exports